Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

Documenti analoghi

• Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
  di: Hirani, SP, et al.
  Pubblicazione: (2008)
• Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
  di: Mulligan, K, et al.
  Pubblicazione: (2008)
• Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
  di: Mulligan, Kathleen, et al.
  Pubblicazione: (2013)
• Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
  di: Moncrieffe, H, et al.
  Pubblicazione: (2011)
• The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people
  di: Mulligan, Kathleen, et al.
  Pubblicazione: (2015)